CRVS Corvus Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1626971 · EDGAR
- Bought, last 12 months
- $333.7K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 94 since 2021-08-23, latest 2026-06-15 17:12
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Moore David Scott | Dir | $250.2K | — |
| MILLER RICHARD A MD | Pres, CEO, Dir | $83.5K | — |
| Thompson Peter A. | Dir, 10% | — | — |
Transactions 27
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 17:12 | 2026-06-11 | CRVS | Moore David Scott | Dir | P - Purchase | $11.53 | +21.7K | 21.7K | New | +$250.2K |
| MI | 2026-05-20 16:12 | 2026-05-18 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $12.04 | +6,932 | 1.20M | +0.6% | +$83.5K |
| DM | 2026-01-30 | 2026-01-28 | CRVS | Thompson Peter A. | Dir, 10% | M - OptEx | $5.33 | +210.0K | 120.0K | New | +$1.12M |
| DI | 2025-07-01 | 2025-06-27 | CRVS | Thompson Peter A. | Dir, 10% | X - OptEx | $3.50 | +1.40M | 8.34M | +20% | +$4.89M |
| DI | 2025-07-01 | 2025-06-27 | CRVS | Thompson Peter A. | Dir, 10% | S - Sale+OE | $4.16 | -1.18M | 7.17M | -14% | -$4.89M |
| DI | 2025-07-01 | 2025-06-27 | CRVS | ORBIMED ADVISORS LLC | Dir, 10% | S - Sale+OE | $4.16 | -1.18M | 7.17M | -14% | -$4.89M |
| DI | 2025-07-01 | 2025-06-27 | CRVS | ORBIMED ADVISORS LLC | Dir, 10% | X - OptEx | $3.50 | +1.40M | 8.34M | +20% | +$4.89M |
| D | 2025-06-06 | 2025-06-04 | CRVS | Jones William Benton | See Remarks | M - OptEx | $3.50 | +19.4K | 173.1K | +13% | +$67.7K |
| D | 2025-05-09 | 2025-05-07 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | M - OptEx | $3.50 | +559.1K | 1.14M | +97% | +$1.96M |
| I | 2024-05-14 | 2024-05-10 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | G - Gift | $0.00 | -302.0K | 1.19M | -20% | $0 |
| D | 2024-05-07 | 2024-05-06 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.73 | +577.6K | 577.6K | New | +$999.3K |
| D | 2024-05-07 | 2024-05-06 | CRVS | Jones William Benton | See Remarks | P - Purchase | $1.73 | +20.0K | 153.8K | +15% | +$34.6K |
| 2023-05-16 | 2023-05-15 | CRVS | Grais Linda | Dir | P - Purchase | $2.45 | +10.0K | 10.0K | New | +$24.5K | |
| 2022-12-20 | 2022-12-20 | CRVS | Jones William Benton | See Remarks | P - Purchase | $0.79 | +20.0K | 133.8K | +18% | +$15.8K | |
| MI | 2022-12-15 | 2022-12-13+ | CRVS | LEA LEIV | CFO | P - Purchase | $0.7518 | +34.0K | 129.2K | +36% | +$25.6K |
| MI | 2022-12-15 | 2022-12-13+ | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $0.7467 | +60.0K | 1.49M | +4% | +$44.8K |
| I | 2022-09-28 | 2022-09-28 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $0.76 | +25.0K | 1.39M | +2% | +$19.0K |
| MI | 2022-09-20 | 2022-09-20 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $0.8138 | +20.0K | 1.36M | +1% | +$16.3K |
| MI | 2022-06-28 | 2022-06-24+ | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.01 | +10.0K | 1.35M | +0.7% | +$10.1K |
| MI | 2022-06-06 | 2022-06-02+ | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $0.9842 | +5,890 | 1.34M | +0.4% | +$5,797 |
| I | 2022-04-01 | 2022-03-31 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.64 | +15.0K | 1.33M | +1% | +$24.6K |
| MI | 2022-03-17 | 2022-03-16+ | CRVS | LEA LEIV | CFO | P - Purchase | $1.57 | +49.0K | 85.4K | +135% | +$77.0K |
| MI | 2022-03-17 | 2022-03-15+ | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.49 | +30.0K | 1.31M | +2% | +$44.7K |
| MI | 2021-10-01 | 2021-09-30+ | CRVS | EcoR1 Capital, LLC | 10% | S - Sale | $5.01 | -5.00M | 81.1K | -98% | -$25.04M |
| I | 2021-09-22 | 2021-09-20 | CRVS | OrbiMed Capital GP V LLC | Dir, 10% | S - Sale | $6.09 | -1.11M | 6.94M | -14% | -$6.76M |
| I | 2021-09-22 | 2021-09-20 | CRVS | Thompson Peter A. | Dir, 10% | S - Sale | $6.09 | -1.11M | 6.94M | -14% | -$6.76M |
| I | 2021-08-23 | 2021-08-20 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.93 | +10.0K | 1.29M | +0.8% | +$19.3K |